| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
59,635 | 54,113 | 44,311 | 42,146.9820 | 39,603.0230 |
|
Cost of Revenue
|
-27,131 | -24,519 | -20,289 | -20,288.5660 | -20,706.7360 |
|
Gross Profit
|
32,504 | 29,594 | 24,022 | 21,858.4160 | 18,896.2870 |
| Selling, General and Administrative Expenses
|
-21,465 | -20,538 | -16,529 | -14,403.0740 | -15,115.9010 |
|
Research and Development Expenses
|
-9,179 | -6,884 | -7,003 | -7,907.3740 | -7,571.3870 |
| Depreciation, Amortization and Depletion
|
-1,691 | -1,670 | -1,752 | -1,834.5700 | -1,898.7010 |
|
Operating Income/Expenses
|
-32,335 | -29,092 | -25,284 | -24,145.0180 | -24,585.9890 |
|
Total Operating Profit/Loss
|
169 | 502 | -1,262 | -2,286.6020 | -5,689.7020 |
| Total Net Finance Income/Expense
|
-498 | -1,070 | -1,587 | -1,509.4580 | -1,070.0850 |
| Net Investment Income
|
-245 | -328 | 233 | -211.1530 | 682.7740 |
| Irregular Income/Expenses
|
0 | 16 | 0 | 2,332.7020 | 0 |
|
Non-Operating Income/Expenses, Total
|
-743 | -1,382 | -1,354 | 612.0910 | -387.3110 |
|
Pretax Income
|
-574 | -880 | -2,616 | -1,674.5110 | -6,077.0130 |
|
Provision for Income Tax
|
-273 | -112 | -12 | -10.6860 | 881.5970 |
|
Net Income from Continuing Operations
|
-847 | -992 | -2,628 | -1,685.1970 | -5,195.4160 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-847 | -992 | -2,628 | -1,685.1970 | -5,195.4160 |
|
Net Income after Non-Controlling/Minority Interests
|
-848 | -992 | -2,628 | -1,685.1970 | -5,195.4160 |
|
Net Income Available to Common Stockholders
|
-848 | -992 | -2,628 | -1,685.1970 | -5,195.4160 |
|
Diluted Net Income Available to Common Stockholders
|
-848 | -992 | -2,628 | -1,685.1970 | -5,195.4160 |
| Basic EPS
|
-0.02 | -0.02 | -0.05 | -0.04 | -0.12 |
| Diluted EPS
|
-0.02 | -0.02 | -0.05 | -0.04 | -0.12 |
|
Basic Weighted Average Shares Outstanding
|
53,374.1520 | 51,195.9890 | 48,386.9260 | 44,595.9420 | 44,498.4180 |
|
Diluted Weighted Average Shares Outstanding
|
53,374.1520 | 51,195.9890 | 48,386.9260 | 44,595.9420 | 44,498.4180 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-76 | 190 | -1,029 | -244.7960 | -5,130.9070 |
|
EBITDA
|
1,615 | 1,860 | 723 | 1,589.7740 | -3,232.2060 |
|
Normalized EBITDA
|
3,653 | 3,203 | 1,243 | -202.9700 | -2,285.9650 |
|
Normalized Income
|
885.3000 | 149.5500 | -2,186 | -3,008.0628 | -4,386.4471 |
|
Total Unusual Items
|
2,038 | 1,343 | 520 | -1,792.7440 | 946.2410 |
|
Total Unusual Items Excluding Goodwill
|
2,038 | 1,343 | 520 | -1,792.7440 | 946.2410 |
12/31/2022 - 9/15/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade